Events & Presentations

About DarioHealth

DarioHealth Corp. (NASDAQ:DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition digital therapeutics platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. 

 Our user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results.  Making the right thing to do the easy thing to do.

Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers.  To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.

Our Mission 

Dario is on a mission to drive the behavior change that powers better health.

DarioHealth Management’s Investor Webinar and Live Q&A

On September 12th, 2024, Erez Raphael, CEO, and Steven Nelson, Chief Commercial Officer, provided a thorough overview of the company and highlighted the inflection point that the business is reaching in its commercial growth. Discussion topics included Twill/Dario product integration milestones, market position, pipeline opportunities, and refined go-to-market strategies across health plans, employers, and pharma under Steven’s leadership. A live investor Q&A at the end of the session highlighted areas of market interest.

Use the link below to access the webinar replay:
https://us02web.zoom.us/rec/share/d5ska5cQCY1N-0N4gVgIbSehr761TZulPCx1AhUpWBm_prtBg_AlnLcujqh38cfJ.P8vnosvWpZWAyFZs?startTime=1726163439000

Passcode: r8?kH7QN

DarioHealth Management Fireside Chat at 2024 Cowen Healthcare Conference

Erez Raphael, CEO, and Rick Anderson, President, participated in a fireside chat at the Cowen Healthcare conference on March 6th, 2024 where they discussed the latest developments at Dario. Topics include:

Dario/Twill overview, Aetna launch, B2B growth, the market for multi-condition solutions, Winning new customers, GLP-1s, the Sanofi partnership and the 2024 outlook.

Use the link below to access the replay:
https://wsw.com/webcast/cowen154/drio/2016052.

Conference Call Announcing DarioHealth’s Acquisition of Twill

Dario and Twill management hosted a conference call on February 21st, 2024 announcing Dario’s strategic acquisition of Twill, a leader in digital-led care. The combination enables Dario to create one of the most comprehensive digital offerings in the market for chronic conditions, spanning a wide spectrum of health and well-being needs from emotional health to the costliest chronic conditions. The transaction creates immediate scale, with three of the top eight national health plans, multiple Fortune 100 employers and several major pharmaceutical companies as customers.

Use these links to access the replay and transcript.

DarioHealth Investor Day Presentation on October 17th 2023

DarioHealth hosted an Investor Day on October 17th, 2023 in NYC. In a discussion about the rise of digital health and the clinical research shaping its future, the Dario management team was joined by respected industry leaders including Arnaud Robert, respected technology expert and former head of digital for Sanofi and Nike, and Felix Lee, U.S. Digital Healthcare Medical Head, Sanofi U.S.

A Dario client along with several members shared how these solutions are changing behaviors and improving health by delivering personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Dario’s executive management team provided a deep dive into the company’s product and market growth plans and highlighted the full potential of the company’s user-centric, multi-chronic condition digital health platform.

Hear what questions investors had for the team during the live Q&A session at the end of the presentation.

DarioHealth Investor Presentation